Pfizer(PFE) - 2025 Q2 - Quarterly Results
Exhibit 99 Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance NEW YORK, Tuesday, August 5, 2025 — Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2025 and reaffirmed its 2025 Revenue guidance while raising guidance for Adjusted diluted EPS. (1) (2) EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and CEO of Pfizer: "Pfizer had another strong quarter of focused execution and we're pleased with our progress in advancing our R&D pipeline, driving our com ...